Principal Investigator: Dr. Joseph Pickrell
New York Genome Center, 101 Avenue of the Americas, 6th Floor, New York, NY 10013, United StatesTags: 1138, Mendelian randomization, population genetics
Professor Molly Przeworski
Collaborating Institutions and Address
Columbia University, Biological Sciences, 606A Fairchild Center, M.C. 2424, New York, NY10027, United States
- To use genomic approaches to identify risk factors for a set of common diseases of particular importance in development and aging. In particular, we will focus on metabolic phenotypes (disease like type 2 diabetes, and phenotypes like BMI), reproductive phenotypes (like number of children and age at menarche), and common causes of death (cancer, heart disease, and neurological disease).
2. To determine the influence of natural selection (if any) on the frequencies of alleles influencing disease risk.
1b: The purpose of the UK Biobank is to improve the prevention, diagnosis, and treatment of illness. We aim to discover genetic and environmental risk factors that have causal influences on disease risk, and to measure the impact of these alleles on evolutionary fitness.
1c: Genomic research has identified thousands of variants that influence human traits like cholesterol levels, platelet counts, and blood pressure, but the influence of these traits on disease remains controversial. We will use novel statistical approaches to identify causal relationships between traits. We will also test whether these alleles influence overall mortality at different ages.
1d: The full cohort.